Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Receivables - Other: 2019

Historic Receivables - Other for Keros Therapeutics (KROS) over the last 1 years, with Dec 2019 value amounting to $922,000.

  • Keros Therapeutics' Receivables - Other was N/A to $100,000 in Q2 2021 from the same period last year, while for Jun 2021 it was $100,000, marking a year-over-year change of. This contributed to the annual value of $922,000 for FY2019, which is N/A change from last year.
  • As of FY2019, Keros Therapeutics' Receivables - Other stood at $922,000.
  • Over the past 5 years, Keros Therapeutics' Receivables - Other peaked at $922,000 during FY2019, and registered a low of $922,000 during FY2019.
  • Over the past 1 years, Keros Therapeutics' median Receivables - Other value was $922,000 (recorded in 2019), while the average stood at $922,000.